![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Xenomics Closes $2.9 Million Financing
Xenomics Closes $2.9 Million Financing
February 3, 2005
Xenomics, a developer of next-generation molecular diagnostic techniques for medical and life sciences applications, has announced the closing of a private placement financing totaling $2.9 million. The proceeds will fund expansion of the company's research and commercialization of its proprietary solutions in a range of key medical and life science markets.
MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqGgV0bKbmdm0yJu1mtG)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct